Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20999.1Germany
BF.7.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BQ.1.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DN.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DN.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DN.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DN.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BQ.1.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BQ.1.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
BQ.1.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BN.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.23ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used